wangvc Inflection Daily · 2026-10-31

Today in three sentences

1. Global chip stocks sold off sharply in a single day: AMD closed at $504.8, down 10.9%, and Oracle fell 6.4% to $130.67, triggered by Intel's weak Q4 guidance; the Philadelphia Semiconductor Index fell more than 7% in a day (Benzinga). There was no new trading on 10-31, so all US equity, A-share, and commodity readings here are from the 10-30 close; crypto trades around the clock, so BTC uses the 10-31 reading. What the market is discounting has shifted from AI demand itself to how that demand is being financed.
2. Chipmakers have started financing their own customers: Broadcom is leading a $63bn shell company that buys chips to lease to Anthropic and guarantees their residual value, while Nvidia, AMD, and Broadcom plan to subscribe up to $5bn of Meta's nearly $100bn new share financing (10-31, AIWeekly/QuiverQuant) — part of demand is being funded by the sellers themselves.
3. Gold fell 3.31% to $3874.86, a 12-month low (10-30, TickDB), and the Fed's decision to hold steady on 10-29 did nothing to support it: both the safe-haven and inflation-hedge trades failed at once, suggesting this round is a cross-asset liquidity squeeze, not sector-specific bad news.

Main thread: discount-rate repricing (Day 3, since 10-29) · Today's change: all the incremental news shifted to the who's-paying side — Broadcom's $63bn shell company and Meta's new share financing both closed the same day (10-31)

There was no new trading on the rates side today: the 2-year yield at 4.594% and the 30-year at 5.309% are frozen at the 10-30 close; the only real change in this chain is the 2-10 year spread widening to 38bp (10-30, 9bp wider than 10-28). All the new evidence sits on the who's-paying side, in three parts: banks and Blackstone set up an SPV (a shell company created for a single deal) to buy chips and lease them to Anthropic, with Broadcom guaranteeing the equipment's residual value; Meta's new shares are being subscribed by its own chip suppliers; and Oracle capped new external financing at $20bn through fiscal 2030, signaling it will lean more on supplier financing going forward (all 10-31). Sellers' revenue is being propped up by their own balance sheets — that is the direct reason chip and cloud stocks were discounted together on the same day (10-30).

The counterargument deserves a clear statement: the five hyperscalers' median capex growth YoY in their latest quarterly reports is 114.4% (quarter-end 08-31 to 09-30, SEC XBRL basis), and cash flow is still expanding. But the gap is real: Morgan Stanley projects hyperscalers' cash capex gap will exceed $200bn in 2027 (10-30).

Private credit's three lights

Two of three lights are on, unchanged from yesterday. (1) BDCs (listed private-credit vehicles) have a median discount of -10.7% and a median drawdown of 18.0% from their 52-week high (10-30), while their reported NAV still dates to the Q2 report from 6-30 (already 4 months stale) — on. (2) The exit for semi-liquid funds is pricing in: KKR FS Income Trust Select's Q3 redemption requests came in at 5.06%, slightly above the 5% cap but were paid in full, and Blue Owl OCIC's third-party secondary tender is priced at a 20% discount to NAV (both 10-30) — no hard redemption gate has been triggered, but the discount itself is the price of the exit — on. (3) The CCC−BB spread is 1131bp while the high-yield composite OAS is only 3.26% (both 10-29, FRED): the composite index shows no stress, but the weakest tier is very tight — half-on, not counted. Stress has moved to where there's no daily pricing.

Twelve domains

AI — Bellwethers fell across the board: Nvidia dropped 4.2% to $204.64, Micron fell 5.3%, and Broadcom fell 5.5% (10-30). This dashboard's monetization gap (capex growth minus API price growth) is -13.8pp (10-31); the API usage data is frozen at 2026-08 and today's read does not depend on it.

BTC — Bitcoin at $77,559 (10-31) is just 2.4% above the short-term holder average cost basis of $75,711. The 4-hour/daily RSI at 40.2/36.2 leans bearish while the weekly RSI of 51.3 is neutral (both 10-31); the accumulation counter dropped from 9/10 to 0 on 10-30 and restarted at 1/10 on 10-31 — the second time this month it has broken before confirming. Assets stolen from Binance total about $6.36bn, including 18,300 BTC still unrecovered (TRM Labs, 10-29).

Gold — At $3874.86, down 3.31%, down 6.98% over 21 days, 29.69% below its 250-day high of $5510.73 (10-30, TickDB); it would need to gain another 42.2% to retest that high. 63% of institutions have turned bearish while 53% of retail traders remain bullish (Kitco, 10-30).

A-share — The STAR 50 closed at 1160.84, down 5.48%, down 30.11% over 21 days, a 52-week closing low, with only 3 constituents (6%) above their 200-day moving average (all 10-30). But equipment makers' Q3 reports told the opposite story: AMEC's nine-month revenue rose 28.08% YoY, ACM Research Shanghai's order backlog rose 88.2% YoY, and Jiangfeng Electronic's net income rose 102.38% YoY (10-31) — the divergence between price and orders is today's key thing to flag. Markets were closed 10-31; next trading day is 11-02.

Bonds — Readings are frozen at 10-30: the 2-year yield is 4.594%, the 30-year is 5.309%, and the 2-10 year spread widened to 38bp, 9bp wider than 10-28; MOVE jumped 7.1% in a single day to 100.21; the 10-year TIPS real yield is 2.63% and breakeven inflation is 2.34% (10-29/10-30). The FOMC held rates at 3.75%-4.00% on 10-29, with an unusual 10-2 split vote.

Congress — Goldman Sachs fell 3.58% to $894.55; over the past 30 days there have been 5 disclosed trades, 4 buys and 1 sell (price data 10-30, filings 10-31). McCormick disclosed three purchases of Goldman Sachs corporate bonds worth $600K-$1.25M on 10-29; Sessions sold more than 25 blue-chip stocks in a single day on 10-27, totaling $1.35M-$3.24M (both PTR).

Biotech — XBI fell 1.15% to $155.98, outperforming the S&P 500's 1.82% drop (10-30). On 10-25, Akeso's ivonescimab beat AstraZeneca's durvalumab head-to-head, cutting the risk of death by 25% in a Phase III biliary tract cancer trial.

Cybersecurity — Fortinet closed at $136.08, down 21.8% from its pre-earnings price of $174.08; three A-share cybersecurity stocks fell 8.1%-10.6% (both 10-30). Q3 earnings diverged sharply: Venustech swung to a profit with nine-month net income of CNY 38.4M and revenue of CNY 1.737bn, up 12.2%, while QAX posted a net loss of CNY 1.169bn, widening 89% YoY, with revenue down 20.2% (10-29/10-30, Tushare) — product vendors are hitting the profit inflection first, while integrated-service providers are still bottoming.

Energy — Brent rose 2.37% on the day to $113.43/barrel, up 86.38% YTD; nuclear-power concept stocks broadly fell 5%-8%, while the UxC uranium price held at $92.55/lb, still up 0.33% on the day (both 10-30) — price and equities diverging. Energy-storage orders (through 10-26): over the past 6 weeks, independent demand accounted for 7 deals worth 12.77GWh/$1.16bn, versus 1 related-party deal making up 16%; independent demand remains the mainstream.

Emerging — All six thematic ETFs fell together after a period of divergence, with BLOK the weakest at $51.25, down 6.29%; CIBR fell 3.78% but is still up 40.38% YTD (both 10-30).

Venture — YTD there have been 68 billion-dollar-plus funding rounds totaling about $429.09bn; Q4 has seen 6 rounds totaling about $33.33bn, with no new additions for 3 days, and AI accounts for 89.32% of the total (both 10-31). Public-market proxies are broadly weak: Fermi is down 67.74% YTD and Figma down 43.03%; of 6 tracked names, only the Renaissance IPO ETF is positive, up 2.29% (10-30).

Winners — Zhipu Z.AI fell 9.10% on the day to HK$483.6 but is still up 303% YTD; MiniMax fell 4.05% to HK$161.3 (both 10-30). Thrive Holdings, OpenAI's investment platform, announced on 10-29 that it would acquire NYSE-listed ADT in a deal valuing the equity at about $7.6bn — its first acquisition of a publicly listed company.

Cross-dashboard links

1. Funding gap ↔ Vendor financing(Winners ↔ AI): Hyperscalers' cash capex gap and Broadcom's $63bn SPV plus chipmakers subscribing to Meta's new share offering (10-31) are two sides of the same coin.
2. Risk assets and safe-haven assets fell on the same day(AI ↔ Gold ↔ Bonds): On the same day tech stocks sold off sharply, gold fell 3.31% and silver fell about 4.9%, while the 10-year real rate of 2.63% should have supported gold prices; MOVE jumped 7.1% to 100.21 (both 10-30) — pointing to a liquidity squeeze, not sector-specific bad news.
3. Domestic substitution: price says no, orders say yes(A-share ↔ Winners): Even as the STAR 50 hit a 52-week low (10-30), ACM Research Shanghai's order backlog rose 88.2% YoY and AMEC's revenue rose 28.08% YoY (10-31) — watch this chain to see which side turns first.

Signals worth watching next

1. 11-03 AMD Q3 earnings: Watch for disclosure of customers purchasing via SPV/leasing structures, along with receivables and guarantee arrangements. If such structures are confirmed, vendor financing moves from a sign to a sourced fact; if explicitly denied and receivables growth YoY trails revenue growth, this side downgrades for the period.
2. 11-06 Nonfarm payrolls and 11-10 CPI: If the 10-year TIPS real yield of 2.63% (10-30) breaks above 2.75%, that confirms rates are still driving pricing; if the real yield falls back below 2.50% while gold stays below $3900, that signals rates no longer hold the pricing power.
3. Private credit's third light: If the CCC−BB spread of 1131bp (10-29) widens further past 1200bp while the high-yield composite OAS stays below 3.5%, all three lights go to 3/3; if it instead narrows back below 1050bp, this light turns off.